Clinical Trial Update: Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the combination of sorafenib and bevacizumab in metastatic colorectal cancer (recurrent or Stage IV colon/rectal cancer); the trial ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-03-03